The extended collaboration will provide services relating to small molecules for both Forbion and BGV portfolio companies active in the biopharmaceutical space
The virtual world makes it possible to visualize, test, understand and predict what cannot be seen, before a patient is treated
Up to 100 million mRNA vaccine doses could be produced in Australia each year
.jpg)
Molbio Diagnostics has been the pioneer in providing access to molecular testing through its Truenat Real Time PCR platform. Sriram Natarajan, Director & CEO, of the company shares his experiences on the journey so far in an interview with Thomas C Thottathil
This is a shot in the arm for the vaccine manufacturers
Dicerna develops RNAi-based therapies to selectively silence genes that cause or contribute to disease
Thermo Fisher Scientific expands diagnostics portfolio to support full qPCR assay development and testing workflow
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
The acquisition expands Takeda’s immuno-oncology and innate immune cell therapy portfolio with novel platforms leveraging T cells for the potential treatment of solid tumours and haematological malignancies
Expands wound care portfolio and aims to drive greater market penetration and availability in the wound dressing category
Subscribe To Our Newsletter & Stay Updated
